Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland

Helmut Salzer; Ralf Otto-Knapp; Torsten Bauer; Folke Brinkmann; Cornelia Feiterna-Sperling; Inna Friesen; null et al.

doi:10.1159/000539410

Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland

Helmut Salzer, Ralf Otto-Knapp, Torsten Bauer, Folke Brinkmann, Cornelia Feiterna-Sperling, Inna Friesen, et al.

Division of Infectious Diseases and Tropical Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	593-600
Number of pages	8
Journal	Respiration
Volume	103
Issue number	9
DOIs	https://doi.org/10.1159/000539410
Publication status	Published - 01 Sept 2024

Fields of science

303031 Tropical medicine
303041 Infectious diseases
302030 Internal medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000539410

Cite this

@article{16b96fc379964e388cc1ed1d269d99eb,

title = "Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland",

author = "Helmut Salzer and Ralf Otto-Knapp and Torsten Bauer and Folke Brinkmann and Cornelia Feiterna-Sperling and Inna Friesen and {et al.}",

year = "2024",

month = sep,

day = "1",

doi = "10.1159/000539410",

language = "English",

volume = "103",

pages = "593--600",

journal = "Respiration",

issn = "1423-0356",

number = "9",

}

TY - JOUR

T1 - Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland

AU - Salzer, Helmut

AU - Otto-Knapp, Ralf

AU - Bauer, Torsten

AU - Brinkmann, Folke

AU - Feiterna-Sperling, Cornelia

AU - Friesen, Inna

AU - et al., null

PY - 2024/9/1

Y1 - 2024/9/1

UR - https://karger.com/res/article/103/9/593/908050/Treatment-of-MDR-Pre-XDR-XDR-and-Rifampicin

UR - http://www.scopus.com/inward/record.url?scp=85203303239&partnerID=8YFLogxK

U2 - 10.1159/000539410

DO - 10.1159/000539410

M3 - Article

C2 - 38810608

SN - 1423-0356

VL - 103

SP - 593

EP - 600

JO - Respiration

JF - Respiration

IS - 9

ER -

Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this